bmiMD vs Ro: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

bmiMD beats Ro overall, scoring 8/10 vs 7.2/10. Ro is more affordable at $149/mo vs $319/mo. Choose bmiMD for budget-first users who want affordable glp-1 access. Choose Ro for users who want fda-approved brand-name glp-1 access includin.

A side-by-side comparison of bmiMD and Ro covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

bmiMD

#9 of 48

8/10

Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.

Visit bmiMD

Ro

#44 of 48

7.2/10

One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.

Visit Ro

Feature	bmiMD	Ro
Our Score	8/10	7.2/10
Starting Price	$319/mo	$149/mo
Medication Type	Both	Brand
Insurance Accepted	No	Yes
Best For	Budget-first users who want affordable GLP-1 access	Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing
Ranking	#9	#44

Pros & Cons Compared

bmiMD

Pros

+Same-day physician consults — one of the few platforms offering telehealth appointments the same day you apply
+80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
+100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
+HSA/FSA accepted for all programs

Cons

−Starting at $289/mo for semaglutide — significantly more expensive than competitors at $99-199/mo
−$29.99 shipping fee per order — most competitors include free shipping
−$50 non-refundable cancellation fee after intake approval — penalizes patients who change their mind

Ro

Pros

+Carries Foundayo (orforglipron) — Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026 — at $149-299/mo via LillyDirect matching
+Direct insurance billing with major carriers — with coverage, Wegovy or Zepbound can cost $0-25/mo copay
+Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
+Claims matched pricing with LillyDirect, NovoCare, and TrumpRx — some of the lowest cash brand prices available

Cons

−Membership and medication are billed separately — readers need to add them together for the all-in monthly cost
−Brand-name only — no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
−Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)

Our Verdict

bmiMD edges out Ro with a score of 8/10 vs 7.2/10. If budget is your priority, Ro starts at $149/mo compared to bmiMD's $319/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. bmiMD offers both brand-name and compounded medications, giving you more flexibility. Choose bmiMD if you want: budget-first users who want affordable glp-1 access. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither bmiMD nor Ro feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review